Kicort 6 Tablet contains Deflazacort 6 mg, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions, including rheumatoid arthritis, systemic lupus erythematosus, allergic reactions, and certain dermatological disorders. Deflazacort exerts its therapeutic effects by modulating the immune response and reducing the production of inflammatory mediators, thereby alleviating symptoms such as swelling, redness, and pain. Kicort 6 is also utilized in the treatment of specific muscular dystrophies and other chronic conditions requiring long-term corticosteroid therapy. The medication should be administered under strict medical supervision, with dosage tailored to the individual patient’s condition and response. It is essential to monitor for potential side effects, which may include immunosuppression, hyperglycemia, osteoporosis, hypertension, and gastrointestinal disturbances. Abrupt discontinuation is discouraged to prevent adrenal insufficiency; tapering of the dose is recommended when discontinuing therapy. Kicort 6 should be used cautiously in patients with infections, diabetes, hypertension, or peptic ulcer disease. Overall, Kicort 6 Tablet offers an effective therapeutic option for controlling inflammation and modulating immune responses in a variety of clinical settings.